PhiNexus | AI Consulting & Business AutomationHyderabad, India · Serving India, GCC & international clients
Life Sciences & Regulated Operations

Use AI and automation where evidence, context and governance matter.

PhiNexus helps life sciences teams structure regulated-document workflows, operational knowledge, evidence traceability and controlled AI assistance without pretending that a generic AI tool can replace validated systems or scientific judgment.

Typical operational friction

Large document volumes, repeated review cycles, controlled procedures, study/quality records, fragmented knowledge, manual evidence assembly, version confusion and growing pressure to govern AI use across the product lifecycle.

Where we help

Controlled information workflows around regulated work.

AreaCommon problemPhiNexus / NexusCore approach
Document intelligenceTeams spend time finding and re-keying information from protocols, reports, forms and supporting records.Extract selected information with validation, evidence and review for approved operational use cases.
Knowledge governancePolicies, SOPs, controlled procedures and scientific/operational knowledge are scattered across repositories.Design taxonomy, ownership, versioning, approval and context-access policies.
AI governanceAI experiments spread without clear context-of-use, risk classification or provider controls.Define use-case boundaries, model/provider policy, human oversight, evidence expectations and audit requirements.
Operational workflowsReview, approval and evidence-assembly processes involve manual handoffs and status chasing.Design deterministic workflows, approval gates, notifications and exception handling around existing validated systems.
Private AISensitive R&D or regulated information cannot be casually sent to public models.Evaluate local/private deployment, data-egress controls and client-approved model access.
NexusCore should not be represented as a replacement for validated GxP systems, electronic quality management systems, LIMS, CTMS, regulatory-information-management systems or required regulatory controls. Integration and validation responsibilities are defined per engagement.
Current regulatory direction

AI use in drug development is moving toward explicit risk, context and lifecycle governance.

FDA and EMA's 2026 good-AI-practice principles emphasize human-centric design, risk-based use, standards, clear context of use, data governance, performance assessment and lifecycle management. That direction strongly supports a governed, documented approach rather than unbounded AI experimentation.

Start with one measurable problem

Where is your team losing time, accuracy or visibility?

We will help determine whether process redesign, automation, document intelligence, governed AI or a combination is the right next step.

Book a Discovery Session